Chemobort Injection
BORTEZOMIB
Chemobort Injection should only be administered by a qualified medical professional The dosage and frequency of administration will be determined by your doctor based on your specific condition and may change over time It is important to follow your doctors instructions exactly and avoid taking the medication incorrectly or in excessive amounts as this can lead to serious side effects It may take several weeks or months to see the benefits of the medication so it is important to continue taking it unless directed otherwise by your doctor Common side effects of Chemobort Injection include fatigue nausea vomiting and loss of appetite It is recommended to drink plenty of fluids during treatment and to avoid driving or operating machinery as the medication may cause fatigue and dizziness This medication may also lower the number of blood cells including red and white blood cells which can increase the risk of infections Regular blood tests will be required to monitor your blood cell count as well as your heart liver and blood uric acid levels Before taking Chemobort Injection it is important to consult with your doctor if you have any liver kidney heart disease or bleeding problems If you experience symptoms such as memory loss or difficulty thinking it is important to seek medical advice Inform your healthcare team about all medications you are currently taking as Chemobort Injection can interact with other drugs This medication is not recommended during pregnancy or while breastfeeding and it is crucial to use effective contraception to prevent pregnancy during treatment


Is Bortemap FDA approved?
Yes, Bortemap is approved by FDA

Is Bortirel a chemotherapy/hormonal drug/ cytotoxic?
Bortirel is not a hormone. It is a chemotherapy/ cytotoxic drug used in the treatment of cancers including multiple myeloma and mantle cell lymphoma

Does Tezomib cause constipation?
Tezomib may cause side effects such as constipation.

How does Bortiad work?
Bortiad belongs to the class of drugs called a proteasome inhibitor. It acts by blocking the action of proteasome, and affects the growth of cancerous (actively growing) cells








